Molecular Diagnostics

MarketReports.com | Pharmaceuticals & Healthcare | Diagnostics |  Molecular Diagnostics

Molecular Diagnostics Market Report: 2011 Edition Price: $800.00 (€608.69) ($960.00 (€730.42) Including VAT at 20%) Publication Date: Jun-2011 Format: PDF Email Pages: 43 Publisher: Koncept Analytics Molecular diagnostics refers to the technique of identifying the presence of any infection or disease, gene mutations, or any type of antigens attacking the body, with the help of the genetic and protein activity patterns of the body. Primarily, the molecular diagnostic tests are performed for three purposes: diagnosis of the infectious diseases, genetic identification and the diagnosis of genetic diseases. Currently, molecular diagnostics represent a small share in the in-vitro diagnostics market, but it offers immense opportunities for growth in future and therefore, is likely to drive the in-vitro diagnostics market in the foreseeable future. Diagnostic tests play an important role in helping the physicians in making decisions, as it has been found that around 80% of the physicians’ decisions are based on the diagnostic reports. With the advent of faster and more accurate molecular tests, coupled with the better sensitivity and specificity of the molecular tests, there has been a shift from the traditional testing methods towards the molecular diagnostic tests. Presently, the molecular diagnostic market is growing on the back of oncology and the infectious disease segment, but in future, when these segments are likely to approach saturation, some of the other segments, including CT/GC, HPV, HAI and Influenza are expected to offer opportunities for growth. The US, Europe and Japan are the major markets for molecular diagnostic tests and together account for a lion’s share in the global market. But in the coming years, with the increasing per capita income, and rising concern regarding healthy living in the emerging countries, like India and China, such countries offer immense potential for growth. Continuous innovation and the technological advancements are some of the factors responsible for accelerating the growth of molecular diagnostic market. However, some of the other major factors affecting the industry include the increasing incidences of cancer, the rising number of cases of hepatitis B and tuberculosis and the availability of various molecular diagnostic tests. The molecular diagnostics market is quite consolidated with the top seven players holding major share of the market, including Roche, Novartis, Gen Probe, QIAGEN, Bayer, Abbott, and Becton Dickinson. The current report analyzes the molecular diagnostic market on the global basis. It also presents a view of the various segments of the market. The report discusses the drivers and challenges prevailing in the molecular diagnostics industry. It presents the competitive conditions prevailing in the global molecular diagnostic market, along with the profiles of four major players in the industry, Roche, Gen-Probe, QIAGEN, and Bayer. By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests. Table of Contents/List of Tables/List of Figures

The Future of Molecular Diagnostics: Innovative technologies driving market opportunities in personalized medicine Price: $3,835.00 (€2,917.89) ($4,602.00 (€3,501.46) Including VAT at 20%) Publication Date: 23-Jun-2010 Please click here for more information or to purchase this report at our partner store Molecular diagnostics, essentially DNA and RNA, is a fast-growing business, made possible by the growing understanding of the human genome. This report analyzes the current and potential world markets for molecular diagnostics, including advances in the field. This report generally forecasts future growth to 2015. The report breaks down market forecasts by type of test and by geography. It indicates which companies have key products in the market place. It also analyzes key drivers of this market.

The Future of Molecular Diagnostics Price: $3,835.00 (€2,917.89) ($4,602.00 (€3,501.46) Including VAT at 20%) Publication Date: 23-Jun-2010 Please click here for more information or to purchase this report at our partner store Molecular diagnostics, essentially the analysis of DNA and RNA at the molecular level, is a fast-growing business, made possible by the growing understanding of the human genome, which has spurred growth in the diagnostic industry.

Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook Price: $3,835.00 (€2,917.89) ($4,602.00 (€3,501.46) Including VAT at 20%) Publication Date: 01-Mar-2010 Please click here for more information or to purchase this report at our partner store This report discusses the drivers, restraints, challenges and opportunities in the global diagnostics market for genomics, proteomics and metabolomics on the basis of technologies, applications, and strategic issues and innovations. The key factor in the current scenario for next-generation omics-based diagnostic technologies is the level of accuracy in the results, followed by the capacity for early detection, and costs.

Global Cancer Biomarkers Market (2010 - 2015) Price Single User $4,650.00 Multi User $5,650.00 Corporate Licence $7,150.00 Enterprise Site Licence $9,000.00 Publication Date: 01-May-2010 Format: pdf Pages: 193 Publisher: MarketsandMarkets Table of Contents Cancer is recognized as a major cause of mortality world over; accounting for 7.4 million (or 13%) of all deaths in 2004. The WHO estimates the incidence of cancer to continue rising to reach an estimated 9.2 million deaths in 2015. The rising prevalence of the disease forms one of the major factors driving the growth of the oncology biomarkers market. Biomarker are chemical, physical, or biological parameters that can be used to indicate disease states. Oncology biomarkers facilitate high-speed, non-invasive cancer diagnosis; and are believed to enhance early cancer detection and screening. The demand for oncology biomarkers is also increasing because of their ability to trace the exact type of cancer and to target patient-specific molecular structure. More...

Molecular Diagnostics Market: Trends and Opportunities Price: $800.00 (€608.69) ($960.00 (€730.42) Including VAT at 20%) Publication Date: 01-Jul-2009 Format: PDF Email Pages: 43 Publisher: Koncept Analytics Molecular diagnostics or the analysis of DNA and RNA at the molecular level - is a fast-growing market, driven by the growing understanding of the human genome. Although a small part of the In-Vitro Diagnostics (IVD) market, molecular diagnostics market is one of the two growth drivers of the IVD industry. In the decision making process of healthcare experts, diagnostics tests have a major influence. Diagnostics tests are a very small percentage cost of medical expenditures but generally accounts for 60-70% of all treatment decisions. And with the advent of molecular diagnostics, there is a growing focus on diagnostics for early detection of diseases. Molecular diagnostics holds immense business potential as it is based on the intention of identifying viruses and infectious diseases more accurately at an earlier stage than currently possible. Molecular diagnostics has also emerged as a potential business opportunity as diagnostics businesses generally fetch higher returns of investment than pharmaceutical and other biotech businesses. The molecular diagnostics industry is growing on the path of continuous innovation and changing technological base and this is creating new opportunities and applications. The major factors that will drive the growth of this industry includes the increasing incidences of various chronic diseases, increasing number of cases of hepatitis B and tuberculosis and the availability of various molecular diagnostics tests. Molecular diagnostics or MDx is the fastest growing segment of the IVD market, also because of the innovation in the industry resulting in the advent of new technologies for genetic testing, faster screening and more precise detection. The report titled “Molecular Diagnostics Industry: Trends and Opportunities” analyzes the molecular diagnostics segment of IVD industry. The study explores the potential business opportunities that exist in the molecular diagnostics industry. Further, factors that are driving the growth of the industry have been assessed. Also, major industry trends have been outlined. The report analyzes the level of competition in the molecular diagnostics industry and also profiles the leading players underlining their sales and business strategies. Further, we have predicted the future growth of the molecular diagnostics industry by combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings. We employed various significant variables that have an impact on this industry and created regression models with SPSS to determine the future direction of the industry. Table of Contents/List of Tables/List of Figures

MarketReports.com | Pharmaceuticals & Healthcare | Diagnostics |  Molecular Diagnostics